Chemoinformaics analysis of 2-Furoic acid, bromomethyldimethylsilyl ester
| Molecular Weight | 263.163 | nRot | 3 |
| Heavy Atom Molecular Weight | 252.075 | nRig | 6 |
| Exact Molecular Weight | 261.966 | nRing | 1 |
| Solubility: LogS | -3.593 | nHRing | 1 |
| Solubility: LogP | 2.858 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 31.6807 |
| nHD | 0 | BPOL | 32.1953 |
| QED | 0.621 |
| Synth | 3.022 |
| Natural Product Likeliness | -0.62 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.262 |
| CACO-2 | -4.523 |
| MDCK | 0.000029 |
| BBB | 0.057 |
| PPB | 0.991357 |
| VDSS | 2.207 |
| FU | 0.00776785 |
| CYP1A2-inh | 0.663 |
| CYP1A2-sub | 0.793 |
| CYP2c19-inh | 0.055 |
| CYP2c19-sub | 0.231 |
| CYP2c9-inh | 0.142 |
| CYP2c9-sub | 0.728 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.372 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.132 |
| CL | 3.63 |
| T12 | 0.869 |
| hERG | 0.022 |
| Ames | 0.743 |
| ROA | 0.475 |
| SkinSen | 0.636 |
| Carcinogencity | 0.815 |
| EI | 0.992 |
| Respiratory | 0.979 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.929623 |